Weronika Ciećko
Biographic Data
| ID | 7872114 |
|---|---|
| NAME | Weronika Ciećko |
| GIVEN NAMES | Weronika |
| FAMILY NAME | Ciećko |
| SIGNATURE | CIEĆKO W |
| AFFILIATIONS | Gdańsk Medical University |
| ORCID | 0000-0002-1496-1924 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result
Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services
Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…
No prominent works on this page.
Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result
Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services
Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…
Business (2 works) · Environmental health (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Medicine (2 works) · Population (2 works) · Economic growth (1 works) · Economics (1 works) · European union (1 works) · Expectancy theory (1 works) · Gerontology (1 works)